FDA phasing out some animal testing in 'win-win' for ethics and public health: commissioner

Dr. Marty Makary pointed out the Biden administration's decision to skip key committee meetings when authorizing vaccines in response to a top Democrat's question. FIRST ON FOX -- The Food and Drug Administration is phasing out an animal testing requirement for antibody therapies and other drugs in favor of testing on materials that mimic human organs, the FDA announced on Thursday. "For too long, drug manufacturers have performed additional animal testing of drugs that have data in broad human use internationally. This initiative marks a paradigm shift in drug evaluation and holds promise to accelerate cures and meaningful treatments for Americans while reducing animal use," FDA Commissioner Martin A. Makary, said in comment provided to Fox News Digital. "By leveraging AI-based computational modeling, human organ model-based lab testing, and real-world human data, we can get safer treatments to patients faster and more reliably, while also reducing R&D costs and drug prices. It is a win-win for public health and ethics."